Showing 291-300 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells | East Tennessee State University | Anoop Arunagiri | Cures | 01-August-2025 to 31-July-2027 | $241,431.00 |
| ACTin1 for DD: Developing and Testing a Digital Single Session Acceptance and Commitment Therapy Intervention for Type 1 Diabetes Distress | Duke University | Max Roberts | Improving Lives | 01-April-2026 to 31-March-2029 | $241,710.00 |
| Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling | Duke University | Rhonda Merwin | Improving Lives | 01-July-2022 to 30-June-2027 | $2,758,224.22 |
| Broad Scope CMC, Non-Clinical, and Regulatory Support | Dark Horse Consulting | Nathan Manley | Cures | 01-September-2025 to 31-December-2026 | $85,000.00 |
| Brown University IND Readiness Gap Analysis | Dark Horse Consulting | Nathan Manley | Cures | 01-June-2025 to 31-December-2025 | $87,770.00 |
| Type 1 Diabetes Consortium – New Onset Workstream | Critical Path Institute (C-Path) | Joseph Hedrick | Cures | 28-October-2022 to 31-December-2025 | $1,132,723.00 |
| Type 1 Diabetes Consortium – Core and Prevention Workstream | Critical Path Institute (C-Path) | Sarah David | Cures | 01-July-2022 to 30-June-2025 | $800,270.00 |
| Clinical Translation of NICHE for pancreatic islet transplantation for T1D | Continuity Biosciences | Alessandro Grattoni | Cures | 01-March-2026 to 28-February-2030 | $2,675,316.00 |
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-December-2026 | $900,000.00 |
| ALIGN-T1D Start-Up Secretariat | Clinton Health Access Initiative (CHAI) | Colin Brown | Mission | 01-October-2025 to 31-March-2027 | $822,000.00 |